76 related articles for article (PubMed ID: 19966142)
1. Physiologically based pharmacokinetic modeling of cyclohexane as a tool for integrating animal and human test data.
Hissink AM; Kulig BM; Kruse J; Freidig AP; Verwei M; Muijser H; Lammers JH; McKee RH; Owen DE; Sweeney LM; Salmon F
Int J Toxicol; 2009; 28(6):498-509. PubMed ID: 19966142
[TBL] [Abstract][Full Text] [Related]
2. Model studies for evaluating the neurobehavioral effects of complex hydrocarbon solvents III. PBPK modeling of white spirit constituents as a tool for integrating animal and human test data.
Hissink AM; Krüse J; Kulig BM; Verwei M; Muijser H; Salmon F; Leenheers LH; Owen DE; Lammers JH; Freidig AP; McKee RH
Neurotoxicology; 2007 Jul; 28(4):751-60. PubMed ID: 17493682
[TBL] [Abstract][Full Text] [Related]
3. Neurobehavioral effects of cyclohexane in rat and human.
Lammers JH; Emmen HH; Muijser H; Hoogendijk EM; McKee RH; Owen DE; Kulig BM
Int J Toxicol; 2009; 28(6):488-97. PubMed ID: 19966141
[TBL] [Abstract][Full Text] [Related]
4. A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans.
Pastino GM; Asgharian B; Roberts K; Medinsky MA; Bond JA
Toxicol Appl Pharmacol; 1997 Jul; 145(1):147-57. PubMed ID: 9221833
[TBL] [Abstract][Full Text] [Related]
5. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
6. Determination of age and gender differences in biochemical processes affecting the disposition of 2-butoxyethanol and its metabolites in mice and rats to improve PBPK modeling.
Corley RA; Grant DM; Farris E; Weitz KK; Soelberg JJ; Thrall KD; Poet TS
Toxicol Lett; 2005 Mar; 156(1):127-61. PubMed ID: 15705493
[TBL] [Abstract][Full Text] [Related]
7. Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans.
Corley RA; Gies RA; Wu H; Weitz KK
Toxicol Lett; 2005 Mar; 156(1):193-213. PubMed ID: 15705496
[TBL] [Abstract][Full Text] [Related]
8. Modeling the toxicokinetics of inhaled toluene in rats: influence of physical activity and feeding status.
Kenyon EM; Benignus V; Eklund C; Highfill JW; Oshiro WM; Samsam TE; Bushnell PJ
J Toxicol Environ Health A; 2008; 71(4):249-65. PubMed ID: 18253891
[TBL] [Abstract][Full Text] [Related]
9. Development of physiologically based pharmacokinetic model for methyl tertiary-butyl ether and tertiary-butanol in male Fisher-344 rats.
Borghoff SJ; Murphy JE; Medinsky MA
Fundam Appl Toxicol; 1996 Apr; 30(2):264-75. PubMed ID: 8812274
[TBL] [Abstract][Full Text] [Related]
10. Predicting age-appropriate pharmacokinetics of six volatile organic compounds in the rat utilizing physiologically based pharmacokinetic modeling.
Rodriguez CE; Mahle DA; Gearhart JM; Mattie DR; Lipscomb JC; Cook RS; Barton HA
Toxicol Sci; 2007 Jul; 98(1):43-56. PubMed ID: 17426107
[TBL] [Abstract][Full Text] [Related]
11. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.
Tardif R; Charest-Tardif G; Brodeur J; Krishnan K
Toxicol Appl Pharmacol; 1997 May; 144(1):120-34. PubMed ID: 9169076
[TBL] [Abstract][Full Text] [Related]
12. Development of a physiologically based pharmacokinetic model for chlorobenzene in F-344 rats.
Thrall KD; Woodstock AD; Kania MR
J Toxicol Environ Health A; 2004 Apr; 67(7):525-36. PubMed ID: 15129550
[TBL] [Abstract][Full Text] [Related]
13. A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species.
Sweeney RE; Langenberg JP; Maxwell DM
Arch Toxicol; 2006 Nov; 80(11):719-31. PubMed ID: 16718492
[TBL] [Abstract][Full Text] [Related]
14. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
[TBL] [Abstract][Full Text] [Related]
15. Model studies for evaluating the neurobehavioral effects of complex hydrocarbon solvents II. Neurobehavioral effects of white spirit in rat and human.
Lammers JH; Emmen HH; Muijser H; Hoogendijk EM; McKee RH; Owen DE; Kulig BM
Neurotoxicology; 2007 Jul; 28(4):736-50. PubMed ID: 17433444
[TBL] [Abstract][Full Text] [Related]
16. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
17. A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human.
Gargas ML; Tyler TR; Sweeney LM; Corley RA; Weitz KK; Mast TJ; Paustenbach DJ; Hays SM
Toxicol Appl Pharmacol; 2000 May; 165(1):63-73. PubMed ID: 10814554
[TBL] [Abstract][Full Text] [Related]
18. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans.
Corley RA; Bormett GA; Ghanayem BI
Toxicol Appl Pharmacol; 1994 Nov; 129(1):61-79. PubMed ID: 7974497
[TBL] [Abstract][Full Text] [Related]
20. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
